Water Quality Testing Kits
MICROSOLV TECHNOLOGY CORPORATION MICRO-SAMPLE MANAGEMENT SYSTEM
502271021 MICRO-SAMPLE MANAGEMENT SYSTEM
MICROSOLV TECHNOLOGY CORPORATION MICRO-SAMPLE MANAGEMENT SYSTEM
502271023 MICRO-SAMPLE MANAGEMENT SYSTEM
MICROSOLV TECHNOLOGY CORPORATION MICRO-SAMPLE MANAGEMENT SYSTEM
502271025 MICRO-SAMPLE MANAGEMENT SYSTEM
Med Vet International Zoetis Anipryl Tablets, 10mg, 30ct.
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
Anipryl (selegiline hydrochloride, L-deprenyl hydrochloride) tablets are indicated for the control of clinical signs associated with canine cognitive dysfunction syndrome (CDS) and control of clinical signs associated with uncomplicated canine pituitary dependent hyperadrenocorticism (PDH).
Med Vet International Norbrook Noromycin 300 La (Oxytetracycline La 300), 300mg/mL, 500mL
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
A sterile, ready to use solution of the broad-spectrum antibiotic oxytetracycline dihydrate. Indicated in the use of beef cattle, non-lactating dairy cattle, calves, including pre-ruminating (veal) calves and swine.
Medchemexpress LLC Tri-GalNAc-DBCO | 2765060-22-6 | 96.6% | 1950.18 | C91H144N12O34 | 10 MG
Trivalent GalNAc-DBCO is a synthetic trivalent N-acetylgalactosamine (GalNAc) ligand functionalized with a dibenzocyclooctyne (DBCO) moiety. It is intended for strain-promoted alkyne-azide cycloaddition (SPAAC) to enable copper-free click conjugation to azide-modified oligonucleotides and other biomolecules, and can direct conjugated cargo to the asialoglycoprotein receptor (ASGPR) for hepatocyte targeting and lysosomal trafficking.
- Enables copper-free click conjugation via strain-promoted alkyne-azide cycloaddition.
- Designed for conjugation to azide-modified oligonucleotides and biomolecules.
- Triantennary GalNAc motif targets ASGPR for liver-directed delivery.
- High purity suitable for biochemical and conjugation workflows.
- Available in small-scale 10 mg packs for research use.